2017 Q4 report, October-December for Panion Animal Health AB
Period October-December · Net sales: kSEK 0 (0). · Operating profit: kSEK -854 (-643). · Earnings per share: SEK -0,32 (-0,09). · Liquidity at the end of the period: kSEK 2 124 (306) Period January-December · Net sales: kSEK 0 (0). · Operating profit: kSEK -4 200 (-692). · Earnings per share: SEK -0,32 (-0,09). · Liquidity at the end of the period: kSEK 2 124 (306) Milestones October-December 2017 · • Panion’s epilepsy drug candidate shows positive initial results in a long-term study by CombiGene, which was published on December 7, 2017. · Panion’